Skip to main content
NCBI home page
Immunology logoLink to Immunology
. 1990 Feb;69(2):237–242.

Stimulation of human rheumatoid synovial cells by non-lethal complement membrane attack.

R H Daniels 1, W A Houston 1, M M Petersen 1, J D Williams 1, B D Williams 1, B P Morgan 1
PMCID: PMC1385595  PMID: 2155179

Abstract

The effects of non-lethal complement attack on cultured human rheumatoid synovial cells have been investigated by measuring a variety of parameters. Within 3-4 min of initiating non-lethal complement membrane attack there was a rise in reactive oxygen metabolite release from cultured synovial cells, which slowly returned to basal levels over a period of 45 min. The response was dependent on the formation of the complete C5b-9 complex. Prostaglandin E2 was also released during non-lethal attack in a biphasic manner, an early phase of release occurring within the first hour and a second, larger phase commencing at 4 hr and rising to levels of over 1000 ng/10(6) cells at 24 hr, compared to control levels at this time of less than 100 ng/10(6) cells. This response was dependent on the formation of the C5b-8 complex but did not require C9. Removal of extracellular calcium reduced release of prostaglandin E2 to background levels, and inclusion of an inhibitor of protein synthesis abolished the second phase of release but not the first phase. Non-lethal attack caused release of small amounts of leukotriene B4 but no detectable release of tumour necrosis factor.

Full text

PDF
237

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abraha A., Morgan B. P., Luzio J. P. The preparation and characterization of monoclonal antibodies to human complement component C8 and their use in purification of C8 and C8 subunits. Biochem J. 1988 Apr 1;251(1):285–292. doi: 10.1042/bj2510285. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Burmester G. R., Dimitriu-Bona A., Waters S. J., Winchester R. J. Identification of three major synovial lining cell populations by monoclonal antibodies directed to Ia antigens and antigens associated with monocytes/macrophages and fibroblasts. Scand J Immunol. 1983 Jan;17(1):69–82. doi: 10.1111/j.1365-3083.1983.tb00767.x. [DOI] [PubMed] [Google Scholar]
  3. Dayer J. M., Krane S. M., Russell R. G., Robinson D. R. Production of collagenase and prostaglandins by isolated adherent rheumatoid synovial cells. Proc Natl Acad Sci U S A. 1976 Mar;73(3):945–949. doi: 10.1073/pnas.73.3.945. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Discipio R. G., Gagnon J. Characterization of human complement components C6 and C7. Mol Immunol. 1982 Nov;19(11):1425–1431. doi: 10.1016/0161-5890(82)90189-4. [DOI] [PubMed] [Google Scholar]
  5. Gitter B. D., Labus J. M., Lees S. L., Scheetz M. E. Characteristics of human synovial fibroblast activation by IL-1 beta and TNF alpha. Immunology. 1989 Feb;66(2):196–200. [PMC free article] [PubMed] [Google Scholar]
  6. Gowen M., Wood D. D., Ihrie E. J., Meats J. E., Russell R. G. Stimulation by human interleukin 1 of cartilage breakdown and production of collagenase and proteoglycanase by human chondrocytes but not by human osteoblasts in vitro. Biochim Biophys Acta. 1984 Feb 14;797(2):186–193. doi: 10.1016/0304-4165(84)90121-1. [DOI] [PubMed] [Google Scholar]
  7. Hopkins S. J., Humphreys M., Jayson M. I. Cytokines in synovial fluid. I. The presence of biologically active and immunoreactive IL-1. Clin Exp Immunol. 1988 Jun;72(3):422–427. [PMC free article] [PubMed] [Google Scholar]
  8. Imagawa D. K., Barbour S. E., Morgan B. P., Wright T. M., Shin H. S., Ramm L. E. Role of complement C9 and calcium in the generation of arachidonic acid and its metabolites from rat polymorphonuclear leukocytes. Mol Immunol. 1987 Dec;24(12):1263–1271. doi: 10.1016/0161-5890(87)90120-9. [DOI] [PubMed] [Google Scholar]
  9. Lovett D. H., Haensch G. M., Goppelt M., Resch K., Gemsa D. Activation of glomerular mesangial cells by the terminal membrane attack complex of complement. J Immunol. 1987 Apr 15;138(8):2473–2480. [PubMed] [Google Scholar]
  10. Mayer M. M. Mechanism of cytolysis by complement. Proc Natl Acad Sci U S A. 1972 Oct;69(10):2954–2958. doi: 10.1073/pnas.69.10.2954. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Morgan B. P., Daniels R. H., Watts M. J., Williams B. D. In vivo and in vitro evidence of cell recovery from complement attack in rheumatoid synovium. Clin Exp Immunol. 1988 Sep;73(3):467–472. [PMC free article] [PubMed] [Google Scholar]
  12. Morgan B. P., Daniels R. H., Williams B. D. Measurement of terminal complement complexes in rheumatoid arthritis. Clin Exp Immunol. 1988 Sep;73(3):473–478. [PMC free article] [PubMed] [Google Scholar]
  13. Morgan B. P., Dankert J. R., Esser A. F. Recovery of human neutrophils from complement attack: removal of the membrane attack complex by endocytosis and exocytosis. J Immunol. 1987 Jan 1;138(1):246–253. [PubMed] [Google Scholar]
  14. Morgan B. P., Daw R. A., Siddle K., Luzio J. P., Campbell A. K. Immunoaffinity purification of human complement component C9 using monoclonal antibodies. J Immunol Methods. 1983 Nov 25;64(3):269–281. doi: 10.1016/0022-1759(83)90434-9. [DOI] [PubMed] [Google Scholar]
  15. Morgan B. P. Mechanisms of tissue damage by the membrane attack complex of complement. Complement Inflamm. 1989;6(2):104–111. doi: 10.1159/000463082. [DOI] [PubMed] [Google Scholar]
  16. Neale M. L., Williams B. D., Matthews N. Tumour necrosis factor activity in joint fluids from rheumatoid arthritis patients. Br J Rheumatol. 1989 Apr;28(2):104–108. doi: 10.1093/rheumatology/28.2.104. [DOI] [PubMed] [Google Scholar]
  17. Ohanian S. H., Schlager S. I., Borsos T. Molecular interactions of cells with antibody and complement: influence of metabolic and physical properties of the target on the outcome of humoral immune attack. Contemp Top Mol Immunol. 1978;7:153–180. doi: 10.1007/978-1-4757-0779-3_5. [DOI] [PubMed] [Google Scholar]
  18. Podack E. R., Kolb W. P., Müller-Eberhard H. J. The C5b-6 complex: formation, isolation, and inhibition of its activity by lipoprotein and the S-protein of human serum. J Immunol. 1978 Jun;120(6):1841–1848. [PubMed] [Google Scholar]
  19. Ramm L. E., Whitlow M. B., Mayer M. M. Size of the transmembrane channels produced by complement proteins C5b-8. J Immunol. 1982 Sep;129(3):1143–1146. [PubMed] [Google Scholar]
  20. Salmon J. A., Higgs G. A. Prostaglandins and leukotrienes as inflammatory mediators. Br Med Bull. 1987 Apr;43(2):285–296. doi: 10.1093/oxfordjournals.bmb.a072183. [DOI] [PubMed] [Google Scholar]
  21. Sanders M. E., Kopicky J. A., Wigley F. M., Shin M. L., Frank M. M., Joiner K. A. Membrane attack complex of complement in rheumatoid synovial tissue demonstrated by immunofluorescent microscopy. J Rheumatol. 1986 Dec;13(6):1028–1034. [PubMed] [Google Scholar]
  22. Seeger W., Suttorp N., Hellwig A., Bhakdi S. Noncytolytic terminal complement complexes may serve as calcium gates to elicit leukotriene B4 generation in human polymorphonuclear leukocytes. J Immunol. 1986 Aug 15;137(4):1286–1293. [PubMed] [Google Scholar]
  23. Shirazi Y., Imagawa D. K., Shin M. L. Release of leukotriene B4 from sublethally injured oligodendrocytes by terminal complement complexes. J Neurochem. 1987 Jan;48(1):271–278. doi: 10.1111/j.1471-4159.1987.tb13158.x. [DOI] [PubMed] [Google Scholar]
  24. Waage A., Kaufmann C., Espevik T., Husby G. Interleukin-6 in synovial fluid from patients with arthritis. Clin Immunol Immunopathol. 1989 Mar;50(3):394–398. doi: 10.1016/0090-1229(89)90146-3. [DOI] [PubMed] [Google Scholar]
  25. Wernick R. M., Lipsky P. E., Marban-Arcos E., Maliakkal J. J., Edelbaum D., Ziff M. IgG and IgM rheumatoid factor synthesis in rheumatoid synovial membrane cell cultures. Arthritis Rheum. 1985 Jul;28(7):742–752. doi: 10.1002/art.1780280704. [DOI] [PubMed] [Google Scholar]
  26. Wood D. D., Ihrie E. J., Hamerman D. Release of interleukin-1 from human synovial tissue in vitro. Arthritis Rheum. 1985 Aug;28(8):853–862. doi: 10.1002/art.1780280804. [DOI] [PubMed] [Google Scholar]
  27. Ziff M., Cavender D., Haskard D. Pathogenetic factors in rheumatoid synovitis. Br J Rheumatol. 1988;27 (Suppl 2):153–156. doi: 10.1093/rheumatology/xxvii.suppl_2.153. [DOI] [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES